0.00Open0.05Pre Close0 Volume2.89K Open Interest0.50Strike Price0.00Turnover245.64%IV48.65%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier23DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.4201Delta1.7363Gamma7.41Leverage Ratio-0.0019Theta0.0001Rho3.11Eff Leverage0.0004Vega
bluebird bio Stock Discussion
bluebird bio to Present Additional Long-Term Follow-up Data from Gene Therapy Programs in Sickle Cell Disease and Beta-Thalassemia at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition
No comment yet